seri
trifluoromethyl
benzothiazolyl
thiazolyl
ketonecontain
peptid
compound
sarscov
proteas
inhibitor
develop
potenc
evalu
vitro
proteas
inhibitori
assay
three
candid
encourag
result
develop
new
antisar
compound
elsevi
ltd
right
reserv
novemb
report
emerg
sever
acut
respiratori
syndrom
sar
highli
contagi
fatal
respiratori
diseas
infect
individu
patient
die
within
month
due
highli
effici
intern
cooper
two
group
rapidli
report
novel
coronaviru
cov
caus
agent
sar
cov
encod
chymotrypsinlik
proteas
pro
play
pivot
role
replic
viru
pro
cystein
proteas
function
analog
main
picornaviru
proteas
pro
catalyt
dyad
activ
site
cy
act
nucleophil
wherea
function
gener
base
order
find
compound
inhibit
sarscov
numer
pro
inhibitor
describ
includ
c
symmetr
diol
bifunct
aryl
boron
acid
ketoglutamin
analog
isatin
deriv
bunsatur
ester
anilid
benzotriazol
well
glutam
acid
glutamin
peptid
possess
trifluoromethyl
keton
group
report
us
collabor
sinc
recent
anoth
group
howev
effect
therapi
develop
far
still
matter
necess
discov
new
potent
structur
case
diseas
reemerg
previou
report
two
compound
scheme
b
found
moder
sarscov
pro
inhibitor
k
lm
respect
mention
cai
cowork
moder
activ
result
format
typic
cyclic
structur
scheme
compound
b
expect
interact
effect
activ
site
sarscov
pro
herein
report
result
improv
inhibitori
activ
compound
focus
two
strategi
first
keep
trifluoromethylketon
moieti
place
investig
chemic
modif
side
chain
glu
gln
residu
posit
order
block
format
cyclic
structur
scheme
modul
hydrogen
bond
abil
posit
toward
activ
site
well
modifi
amino
acid
residu
posit
second
investig
replac
chemic
warhead
inhibitor
trifluoromethyl
unit
moieti
electronwithdraw
thiazolyl
benzothiazolyl
group
believ
modif
would
valuabl
enhanc
reactiv
covalentadduct
format
activ
site
cystein
residu
sarscov
pro
synthet
point
view
prepar
target
compound
envis
follow
synthet
rout
illustr
scheme
compound
prepar
cbzlgluoh
convert
correspond
oxazolidinon
acid
condit
describ
moor
et
al
amid
next
prepar
coupl
compound
four
kind
amin
use
standard
coupl
method
peptid
result
excel
yield
compound
convert
onepot
reaction
see
front
matter
seri
trifluoromethyl
benzothiazolyl
thiazolyl
ketonecontain
peptid
compound
sarscov
proteas
inhibitor
develop
potenc
evalu
vitro
proteas
inhibitori
assay
three
candid
encourag
result
develop
new
antisar
compound
elsevi
ltd
right
reserv
novemb
report
emerg
sever
acut
respiratori
syndrom
sar
highli
contagi
fatal
respiratori
diseas
infect
individu
patient
die
within
month
due
highli
effici
intern
cooper
two
group
rapidli
report
novel
coronaviru
cov
caus
agent
sar
cov
encod
chymotrypsinlik
proteas
pro
play
pivot
role
replic
viru
pro
cystein
proteas
function
analog
main
picornaviru
proteas
pro
catalyt
dyad
activ
site
cy
act
nucleophil
wherea
function
gener
base
order
find
compound
inhibit
sarscov
numer
pro
inhibitor
describ
includ
c
symmetr
diol
bifunct
aryl
boron
acid
ketoglutamin
analog
isatin
deriv
bunsatur
ester
anilid
benzotriazol
well
glutam
acid
glutamin
peptid
possess
trifluoromethyl
keton
group
report
us
collabor
sinc
recent
anoth
group
howev
effect
therapi
develop
far
still
matter
necess
discov
new
potent
structur
case
diseas
reemerg
previou
report
two
compound
scheme
b
found
moder
sarscov
pro
inhibitor
k
lm
respect
mention
cai
cowork
moder
activ
result
format
typic
cyclic
structur
scheme
compound
b
expect
interact
effect
activ
site
sarscov
pro
herein
report
result
improv
inhibitori
activ
compound
focus
two
strategi
first
keep
trifluoromethylketon
moieti
place
investig
chemic
modif
side
chain
glu
gln
residu
posit
order
block
format
cyclic
structur
scheme
modul
hydrogen
bond
abil
posit
toward
activ
site
well
modifi
amino
acid
residu
posit
second
investig
replac
chemic
warhead
inhibitor
trifluoromethyl
unit
moieti
electronwithdraw
thiazolyl
benzothiazolyl
group
believ
modif
would
valuabl
enhanc
reactiv
covalentadduct
format
activ
site
cystein
residu
sarscov
pro
synthet
point
view
prepar
target
compound
envis
follow
synthet
rout
illustr
scheme
compound
prepar
cbzlgluoh
convert
correspond
oxazolidinon
acid
condit
describ
moor
et
al
amid
next
prepar
coupl
compound
four
kind
amin
use
standard
coupl
method
peptid
result
excel
yield
compound
convert
onepot
reaction
correspond
ing
trifluoromethylalcohol
whose
cbz
group
deprotect
silica
gel
column
chromatographi
amino
function
result
compound
coupl
appropri
peptid
fragment
peptid
fragment
synthes
accord
known
procedur
final
result
peptid
directli
engag
last
oxid
step
afford
pure
target
compound
moder
overal
yield
rphplc
purif
ch
cn
tfah
system
deriv
thiazoleketon
f
benzothiazoleketon
structur
residu
prepar
shown
scheme
cbzglu
tbu
oh
convert
weinreb
amid
success
coupl
thiazol
benzothiazol
presenc
nbuli
base
afford
keton
b
deprotect
tertbutyl
group
hcooh
result
carboxyl
group
compound
b
coupl
amin
obtain
compound
follow
coupl
peptid
fragment
base
similar
approach
depict
scheme
compound
obtain
moder
yield
hplc
purif
compound
pyrrolidon
structur
side
chain
synthes
differ
approach
shown
scheme
lactam
ester
prepar
commerci
avail
nbocl
glutam
acid
dimethyl
ester
follow
previous
publish
procedur
lactam
ester
hydrolyz
obtain
lactam
acid
follow
synthet
step
depict
scheme
get
desir
compound
dithiazolyl
compound
synthes
start
cbzvalleuoh
scheme
first
convert
succinimid
ester
follow
treatment
lglutam
acid
obtain
compound
dicarboxyl
compound
convert
correspond
cdoubleweinreb
amid
follow
treatment
equiv
thiazol
presenc
nbuli
afford
desir
ncbzprotect
dithiazolylketon
compound
inhibitori
activ
k
first
seri
compound
sarscov
pro
shown
tabl
inhibit
assay
perform
use
procedur
mention
earlier
previou
report
compound
b
scheme
found
moder
sarscov
pro
inhibitor
k
valu
lm
respect
tabl
entri
compound
use
lead
structur
optim
develop
potent
sarscov
pro
inhibitor
compound
first
attempt
modifi
residu
convert
ccarboxyl
acid
compound
n
ndiethylamid
howev
compound
exhibit
lower
inhibitori
activ
lead
compound
plausibl
reason
observ
low
activ
could
attribut
disrupt
hydrogen
bond
interact
posit
activ
site
enzym
unfavor
steric
hindranc
coval
bond
format
cf
keton
moieti
activ
site
cystein
residu
enzym
hand
replac
n
ndiethylamid
compound
nmorpholineand
n
nmethylbenzylamid
increas
inhibitori
activ
tabl
entri
inde
activ
compound
k
valu
lm
respect
fivefold
higher
affin
refer
compound
next
develop
smaller
size
inhibitor
prepar
cf
keton
compound
contain
structur
compound
differ
peptid
chain
length
peptid
chain
length
play
signific
role
inhibit
enzym
form
crucial
hydrogen
bond
interact
howev
observ
chang
activ
neglig
either
increas
decreas
one
residu
peptid
chain
length
compar
entri
commonli
adopt
mechan
inhibit
sarscov
pro
coval
bond
form
carbonyl
group
locat
warhead
inhibitor
activ
site
cystein
residu
enzym
modifi
electroneg
warhead
carbonyl
moieti
could
acceler
coval
bond
format
henc
second
seri
investig
trifluoromethylketon
moieti
replac
electron
withdraw
thiazolyl
benzothiazolyl
counterpart
shown
tabl
compar
trifluoromethylketon
contain
compound
correspond
compound
thiazolylketon
exhibit
drastic
decreas
inhibit
k
lm
entri
howev
thiazolylketon
deriv
n
ndiethylamid
side
chain
slightli
increas
inhibitori
activ
k
lm
entri
cf
keton
deriv
bulki
n
ndiisopropylamid
structur
moreov
pyrrolidin
structur
adapt
side
chain
thiazolylketon
deriv
entri
drastic
increas
inhibitori
activ
k
valu
lm
slightli
smaller
rigid
cyclic
amid
structur
seem
well
accommod
site
introduct
thiazolylketon
side
chain
result
compound
entri
exhibit
decreas
rel
strong
activ
k
lm
comparison
pyrrolidin
deriv
inhibitori
activ
decreas
reduc
peptid
chain
length
compound
compar
entri
littl
improv
inhibitori
activ
observ
warhead
thiazol
replac
benzothiazol
compar
entri
compound
synthes
inhibitor
possess
thiazol
found
potent
sarscov
pro
inhibitor
studi
suggest
synthes
inhibitor
tightbind
substrat
mimet
target
activ
site
pro
similar
trifluoromethyl
keton
compound
thiazol
benzothiazol
keton
compound
show
increas
inhibit
equilibr
proteas
min
thu
inhibit
compound
proteas
time
depend
indic
revers
tightbind
interact
proteas
moreov
better
understand
potent
activ
compound
enzym
comput
molecular
studi
perform
fig
bind
model
sarscov
pro
simul
use
model
packag
moe
chemic
comput
group
inc
montreal
canada
initi
conform
built
chang
structur
similar
ligand
fig
obtain
xray
crystal
data
pdb
id
k
lm
obtain
ref
sever
energi
minim
process
forc
field
addit
perform
water
soak
environ
around
inhibitor
follow
molecular
dynam
simul
simul
moieti
p
p
interact
similar
manner
origin
ligand
except
thiazolyl
keton
benzyloxycarbonyl
moieti
fig
oxoanion
keton
gener
attack
interact
amid
backbon
fig
nitrogen
thiazol
also
contact
hydrogen
bond
interact
interact
indic
accept
uniqu
keton
hand
benzyloxycarbonyl
group
bare
made
hydrophob
interact
suggest
possibl
optim
moieti
conclus
disclos
inhibitori
potenc
compound
contain
warhead
thiazolyl
unit
sarscov
pro
inhibitor
measur
inhibitori
activ
coupl
possibl
structur
modif
reveal
dock
give
us
new
direct
fast
develop
much
potent
inhibitor
investig
new
famili
compound
current
progress
laboratori
cbzvalleunh
